サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/24 | 5,001 | 5,033 | 4,949 | 4,954 | -58 | -1.2% | 94,600 |
| 2023/11/22 | 4,931 | 5,024 | 4,911 | 5,012 | +115 | +2.3% | 100,300 |
| 2023/11/21 | 4,920 | 4,920 | 4,842 | 4,897 | -34 | -0.7% | 180,900 |
| 2023/11/20 | 5,005 | 5,025 | 4,931 | 4,931 | -94 | -1.9% | 176,900 |
| 2023/11/17 | 4,948 | 5,027 | 4,928 | 5,025 | +73 | +1.5% | 203,700 |
| 2023/11/16 | 4,940 | 5,015 | 4,939 | 4,952 | +30 | +0.6% | 218,300 |
| 2023/11/15 | 4,969 | 4,977 | 4,880 | 4,922 | -104 | -2.1% | 242,700 |
| 2023/11/14 | 5,030 | 5,076 | 4,994 | 5,026 | +32 | +0.6% | 205,700 |
| 2023/11/13 | 4,980 | 5,027 | 4,907 | 4,994 | +22 | +0.4% | 271,000 |
| 2023/11/10 | 4,860 | 4,972 | 4,853 | 4,972 | +88 | +1.8% | 353,600 |
| 2023/11/09 | 4,850 | 4,888 | 4,761 | 4,884 | +62 | +1.3% | 215,300 |
| 2023/11/08 | 4,753 | 4,870 | 4,753 | 4,822 | +137 | +2.9% | 348,500 |
| 2023/11/07 | 4,800 | 4,824 | 4,662 | 4,685 | -106 | -2.2% | 195,300 |
| 2023/11/06 | 4,819 | 4,830 | 4,730 | 4,791 | -20 | -0.4% | 220,900 |
| 2023/11/02 | 4,880 | 4,898 | 4,782 | 4,811 | -57 | -1.2% | 192,300 |
| 2023/11/01 | 4,876 | 4,898 | 4,816 | 4,868 | +62 | +1.3% | 222,500 |
| 2023/10/31 | 4,673 | 4,828 | 4,666 | 4,806 | +178 | +3.8% | 340,500 |
| 2023/10/30 | 4,611 | 4,630 | 4,558 | 4,628 | +12 | +0.3% | 148,000 |
| 2023/10/27 | 4,533 | 4,643 | 4,489 | 4,616 | +57 | +1.3% | 263,300 |
| 2023/10/26 | 4,553 | 4,588 | 4,478 | 4,559 | -23 | -0.5% | 234,500 |
| 2023/10/25 | 4,585 | 4,652 | 4,542 | 4,582 | -8 | -0.2% | 272,000 |
| 2023/10/24 | 4,356 | 4,600 | 4,356 | 4,590 | -46 | -1% | 1,484,100 |
| 2023/10/23 | 4,590 | 4,798 | 4,590 | 4,636 | +61 | +1.3% | 679,800 |
| 2023/10/20 | 4,544 | 4,609 | 4,502 | 4,575 | -27 | -0.6% | 173,500 |
| 2023/10/19 | 4,600 | 4,652 | 4,591 | 4,602 | -63 | -1.4% | 179,600 |
| 2023/10/18 | 4,725 | 4,729 | 4,657 | 4,665 | -40 | -0.9% | 211,300 |
| 2023/10/17 | 4,703 | 4,779 | 4,679 | 4,705 | +51 | +1.1% | 381,500 |
| 2023/10/16 | 4,649 | 4,719 | 4,638 | 4,654 | +53 | +1.2% | 305,000 |
| 2023/10/13 | 4,573 | 4,649 | 4,557 | 4,601 | -8 | -0.2% | 218,400 |
| 2023/10/12 | 4,619 | 4,640 | 4,573 | 4,609 | +60 | +1.3% | 180,100 |
| 2023/10/11 | 4,562 | 4,606 | 4,517 | 4,549 | +16 | +0.4% | 193,900 |
| 2023/10/10 | 4,515 | 4,568 | 4,491 | 4,533 | +75 | +1.7% | 188,500 |
| 2023/10/06 | 4,390 | 4,499 | 4,390 | 4,458 | +67 | +1.5% | 151,900 |
| 2023/10/05 | 4,375 | 4,406 | 4,346 | 4,391 | +16 | +0.4% | 169,000 |
| 2023/10/04 | 4,447 | 4,505 | 4,374 | 4,375 | -89 | -2% | 231,900 |
| 2023/10/03 | 4,495 | 4,517 | 4,436 | 4,464 | +65 | +1.5% | 263,200 |
| 2023/10/02 | 4,578 | 4,587 | 4,388 | 4,399 | -179 | -3.9% | 218,600 |
| 2023/09/29 | 4,621 | 4,621 | 4,511 | 4,578 | -4 | -0.1% | 271,700 |
| 2023/09/28 | 4,555 | 4,630 | 4,516 | 4,582 | -73 | -1.6% | 168,300 |
| 2023/09/27 | 4,597 | 4,655 | 4,557 | 4,655 | +58 | +1.3% | 187,800 |
| 2023/09/26 | 4,664 | 4,665 | 4,548 | 4,597 | -20 | -0.4% | 180,700 |
| 2023/09/25 | 4,591 | 4,617 | 4,532 | 4,617 | +61 | +1.3% | 155,100 |
| 2023/09/22 | 4,527 | 4,589 | 4,521 | 4,556 | -6 | -0.1% | 232,300 |
| 2023/09/21 | 4,532 | 4,609 | 4,530 | 4,562 | -3 | -0.1% | 217,900 |
| 2023/09/20 | 4,579 | 4,669 | 4,527 | 4,565 | -36 | -0.8% | 472,700 |
| 2023/09/19 | 4,587 | 4,626 | 4,533 | 4,601 | +53 | +1.2% | 285,500 |
| 2023/09/15 | 4,491 | 4,599 | 4,461 | 4,548 | +127 | +2.9% | 467,200 |
| 2023/09/14 | 4,402 | 4,431 | 4,362 | 4,421 | +28 | +0.6% | 162,700 |
| 2023/09/13 | 4,394 | 4,448 | 4,367 | 4,393 | +10 | +0.2% | 251,800 |
| 2023/09/12 | 4,333 | 4,402 | 4,318 | 4,383 | +55 | +1.3% | 171,100 |
351～
400
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
